Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study

Suzuki Yuji; Kawashima Shingo; Makino Hiroshi; Doi Matsuyuki; Nakajima Yoshiki

doi:10.4097/kja.22441

추천

검색

자료유형: 학술저널

저자정보: Suzuki Yuji (Department of Anesthesiology and Intensive Care Medicine Hamamatsu University School of Medicine) Kawashima Shingo (Department of Anesthesiology and Intensive Care Medicine Hamamatsu University School of Medicine) Makino Hiroshi (Department of Anesthesiology and Intensive Care Medicine Hamamatsu University School of Medicine) Doi Matsuyuki (Department of Anesthesiology and Intensive Care Medicine Hamamatsu University School of Medicine) Nakajima Yoshiki (Department of Anesthesiology and Intensive Care Medicine Hamamatsu University School of Medicine)

저널정보: 대한마취통증의학회(구 대한마취과학회) Korean Journal of Anesthesiology Korean Journal of Anesthesiology Vol.76 No.2

발행연도: 2023.4

수록면: 143 - 151 (9page)

DOI: 10.4097/kja.22441

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Remimazolam is a novel ultrashort-acting benzodiazepine that has recently become available for general anesthesia. However, the incidence of postoperative nausea and vomiting (PONV) associated with remimazolam remains unknown. In this propensity score-matched, retrospective, observational study, we compared the rates of PONV between remimazolam and propofol.Methods: In this retrospective observational study, propensity score-matching was performed to minimize selection bias. Patients who received total intravenous anesthesia with remimazolam or propofol at the Hamamatsu University Hospital between August 2020 and July 2021 were enrolled in the study. Data on patient demographics, anesthetic agents, and PONV within the first 24 h were collected and analyzed.Results: Of the 1,239 patients who met the study selection criteria, 585 received remimazolam and 684 received propofol. After propensity score matching, 333 matched pairs were further analyzed. Patient demographics and the anesthetic agents used were comparable between the matched cohorts. The incidence of PONV was significantly higher in the remimazolam group than in the propofol group (35% vs. 21%, P < 0.001).Conclusions: The incidence of PONV is higher with remimazolam anesthesia than with propofol anesthesia. The findings of this study require confirmation in larger prospective randomized controlled trials.

#Flumazenil #General anesthesia #Nausea #Postoperative complications #Postoperative nausea and vomiting #Propofol #Remimazolam #Risk factors #Vomiting.

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!